# Rallybio Corporation (RLYB) stock: price and valuation

URL: https://funkfolio.com/stock/RLYB

> Rallybio Corporation (RLYB) trades at $15.29, is worth $85.62M and is priced at 3.3× earnings. Valuation, financials and signals.

---

## Rallybio Corporation (RLYB)

Rallybio Corporation (RLYB) is a healthcare company (biotechnology) based in the United States. The share price is $15.29, down 0.88% on the day, which values the company at $85.62M. Price as of 17 Nov 2026, 22:09 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $15.29 −0.88% today
- **Market value:** $85.62M
- **P/E ratio:** 3.3× last 12 months
- **200-week average:** $17.20 11% below
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 22:09 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Rallybio Corporation in more detail

RLYB trades at 3.3× its last twelve months' earnings, -2.8× next year's expected earnings, 197.3× sales. It sits 11% below its 200-week average of $17.20.

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold RLYB, including Andreas Halvorsen (0.0% of the portfolio).

### Superinvestors holding RLYB

1 of the investors tracked here report a position in their latest 13F filing.

- [Andreas Halvorsen Viking Global Investors](https://funkfolio.com/gurus/andreas-halvorsen) 0.02% of portfolio · $8.4M · Q2 2026

### Rallybio Corporation (RLYB): questions and answers

**What is RLYB's P/E ratio?**

Rallybio Corporation trades at 3.3× its last twelve months' earnings and -2.8× next year's expected earnings.

**What is Rallybio Corporation's market cap?**

Rallybio Corporation is valued at $85.62M at a share price of $15.29.

**Is RLYB above its 200-week moving average?**

No. RLYB is 11.1% below its 200-week average of $17.20. Long-term investors watch that line because strong companies rarely trade below it for long.

**Does RLYB pay a dividend?**

Rallybio Corporation does not currently pay a regular dividend.

**Which famous investors own RLYB?**

In their latest quarterly filings, Andreas Halvorsen (0.0% of the portfolio) hold RLYB. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Rallybio Corporation (RLYB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RLYB

Underlying data: Yahoo Finance; company filings with the SEC.
